Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by James N Ingle

51-100 of 374 results

The influence of letrozole on serum lipid concentrations in postmenopausal women with primary breast cancer who have completed 5 years of adjuvant tamoxifen (NCIC CTG MA.17L).

scientific article published on 7 April 2005

Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker

scientific article published on June 28, 2013

CYP2D6 metabolism and patient outcome in the Austrian Breast and Colorectal Cancer Study Group trial (ABCSG) 8.

scientific article published on 4 December 2012

Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer: an intergroup study

scientific article published on 01 March 1998

A phase II study of ABT-510 (thrombospondin-1 analog) for the treatment of metastatic melanoma

scientific article

Novel methylated biomarkers and a robust assay to detect circulating tumor DNA in metastatic breast cancer.

scientific article

A measles virus vaccine strain derivative as a novel oncolytic agent against breast cancer

scientific article published on 27 April 2006

Metaplastic breast cancer: prognosis and response to systemic therapy

scientific article published on 01 April 1999

Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors

scientific article

Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with metastatic breast cancer. An updated analysis

scientific article

Molecular markers in male breast carcinoma

scientific article published in November 1998

Randomized phase II study of two irinotecan schedules for patients with metastatic breast cancer refractory to an anthracycline, a taxane, or both

scientific article published in July 2004

Tamoxifen use in postmenopausal breast cancer: CYP2D6 matters

scientific article published on 22 October 2012

Tissue composition of mammographically dense and non-dense breast tissue

scientific article published on August 30, 2011

Two concurrent phase II trials of paclitaxel/carboplatin/trastuzumab (weekly or every-3-week schedule) as first-line therapy in women with HER2-overexpressing metastatic breast cancer: NCCTG study 983252.

scientific article

Effect of body weight on the pharmacokinetics of cyclophosphamide in breast cancer patients

scientific article published in January 1987

Randomized trial of bilateral oophorectomy versus tamoxifen in premenopausal women with metastatic breast cancer

scientific article published in February 1986

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer

scientific article published on 04 June 2018

Fulvestrant in women with advanced breast cancer after progression on prior aromatase inhibitor therapy: North Central Cancer Treatment Group Trial N0032.

scientific article published in March 2006

HER2 testing in patients with breast cancer: poor correlation between weak positivity by immunohistochemistry and gene amplification by fluorescence in situ hybridization

scientific article published on 01 February 2002

Efficacy of Letrozole Extended Adjuvant Therapy According to Estrogen Receptor and Progesterone Receptor Status of the Primary Tumor: National Cancer Institute of Canada Clinical Trials Group MA.17

article

Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study

scientific article published on September 14, 2015

Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG intergroup trial MA.17.

scientific article published on 10 March 2008

Coprescription of tamoxifen and medications that inhibit CYP2D6.

scientific article

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy

scientific article published on 31 January 2018

Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects

scientific article

Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis

scientific article published in February 1991

Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen

scientific article published on 10 March 2011

Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial

article

Urine Biomarkers of Risk in the Molecular Etiology of Breast Cancer

scientific article published on January 6, 2009

C-MYC alterations and association with patient outcome in early-stage HER2-positive breast cancer from the north central cancer treatment group N9831 adjuvant trastuzumab trial.

scientific article

Phase III comparison of tamoxifen versus tamoxifen plus ovarian function suppression in premenopausal women with node-negative, hormone receptor-positive breast cancer (E-3193, INT-0142): a trial of the Eastern Cooperative Oncology Group

scientific article

Influence of patient characteristics, socioeconomic factors, geography, and systemic risk on the use of breast-sparing treatment in women enrolled in adjuvant breast cancer studies: an analysis of two intergroup trials

scientific article published on 01 November 1996

Selective Estrogen Receptor Modulators and Pharmacogenomic Variation in ZNF423 Regulation of BRCA1 Expression: Individualized Breast Cancer Prevention

scientific article published on June 13, 2013

Variation in anastrozole metabolism and pharmacodynamics in women with early breast cancer

scientific article

Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy.

scientific article published on May 2002

Patterns of tumor relapse following mastectomy and adjuvant systemic therapy in patients with axillary lymph node-positive breast cancer. Impact of clinical, histopathologic, and flow cytometric factors

scientific article published on 01 August 1993

Demonstration of anti-tumor activity of oncolytic measles virus strains in a malignant pleural effusion breast cancer model

scientific article

Functional role of KLF10 in multiple disease processes

scientific article

p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy

scientific article

Molecular analysis of metaplastic breast carcinoma: high EGFR copy number via aneusomy

scientific article published on April 2008

Differential gene expression of TGF-beta family members and osteopontin in breast tumor tissue: analysis by real-time quantitative PCR

scientific article published on 01 June 2002

Aromatase inhibitors, estrogens and musculoskeletal pain: estrogen-dependent T-cell leukemia 1A (TCL1A) gene-mediated regulation of cytokine expression

scientific article published on March 9, 2012

TBX2 is preferentially amplified in BRCA1- and BRCA2-related breast tumors

scientific article published on 01 July 2002

Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole

scientific article published on October 1, 2012

17q23 amplifications in breast cancer involve the PAT1, RAD51C, PS6K, and SIGma1B genes

scientific article (publication date: October 2000)

Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study

scientific article

Estrogen receptor alpha/beta isoforms, but not betacx, modulate unique patterns of gene expression and cell proliferation in Hs578T cells

scientific article published on August 2007

Combination of paclitaxel and carboplatin as second-line therapy for patients with metastatic melanoma

scientific article

Effect of doxorubicin plus cyclophosphamide on left ventricular ejection fraction in patients with breast cancer in the North Central Cancer Treatment Group N9831 Intergroup Adjuvant Trial

scientific article published on 01 September 2004